drugset / Trial / NCT00097799
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Summary
This study was designed to provide early access to and evaluate the safety of TPV/r in PI-experienced patients with HIV-1 infection.
Timeline
- Start
- 2004-12
- Primary completion
- 2005-08
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ritonavir | Other / unclassified | 200 mg | — |
| Subject | Tipranavir | Small molecule | 500 mg | — |